AlphaSimPlex Group’s Quest Diagnostics DGX Stock Holding History

AlphaSimPlex Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,454	Closed	-$425K	–	92
2021 Q4	$425K	Sell	2,454 -4,545	-65%	-$692K	0.72%	38
2021 Q3	$1.02M	Sell	6,999 -762	-10%	-$111K	0.84%	32
2021 Q2	$1.02M	Sell	7,761 -4,267	-35%	-$559K	0.51%	58
2021 Q1	$1.54M	Sell	12,028 -671	-5%	-$82.7K	0.65%	39
2020 Q4	$1.51M	Buy	12,699 +5,052	+66%	+$616K	0.53%	46
2020 Q3	$876K	Buy	7,647 +1,664	+28%	+$197K	0.4%	97
2020 Q2	$682K	Buy	+5,983	New	+$635K	0.51%	44
2019 Q2	–	Sell	-18,855	Closed	-$1.7M	–	219
2019 Q1	$1.7M	Buy	+18,855	New	+$1.63M	0.57%	53

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

AlphaSimPlex Group's DGX Position: Q1 2022 in Review

AlphaSimPlex Group sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 2,454 shares — an estimated $425K sold.

AlphaSimPlex Group first reported a position in DGX in Q1 2019 and held it in 8 quarters. The position peaked at $1.7M in Q1 2019. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

AlphaSimPlex Group reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
AlphaSimPlex Group sold 2,454 Quest Diagnostics shares in Q1 2022, an estimated $425K.
AlphaSimPlex Group first reported a position in Quest Diagnostics in Q1 2019 and held it in 8 quarters.
AlphaSimPlex Group's Quest Diagnostics position peaked at $1.7M in Q1 2019.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on AlphaSimPlex Group's 13F filing for Q1 2022, filed 10 May 2022.